Research peptides · For laboratory and scientific research in vitro · Not medications · Not approved for consumption · Adults only (18+)
Regenerative Quartet (BPC-157 + GHK-Cu + TB-500 + KPV)
In plain language
Regenerative blend 80 mg — the four leading recovery peptides in one vial. Parallel angiogenesis, collagen synthesis, cell migration and anti-inflammatory NF-κB block.
For researchers
The Regenerative Quartet is a lyophilized blend of the four leading peptides in the category — BPC-157 (10 mg), GHK-Cu (50 mg), TB-500 (10 mg) and KPV (10 mg) — totaling 80 mg in one vial. The premise is parallel activation of four distinct recovery pathways that in the literature work synergistically. BPC-157 accelerates angiogenesis via VEGFR2 and the NO signaling pathway — new capillaries route blood to injured tissue. GHK-Cu delivers copper ions to fibroblasts and activates collagen + elastin synthesis in dermis and fasciae. TB-500 binds G-actin and accelerates cell migration toward sites BPC has already perfused with blood. KPV inhibits NF-κB and reduces TNF-α, IL-6 — silencing the inflammatory noise on which the other three mechanisms compound. In modern research protocols the blend is used for long regenerative cycles (8-12 weeks) where the individual peptides would typically be administered sequentially. Half-lives vary by component (BPC ~6 h, TB-500 2-3 days, GHK-Cu and KPV — short), making protocols flexible. Storage: -20°C lyophilized; reconstituted solution stable 14 days at 2-8°C.
Scientific literature
Information about Регенеративен квартет is based on published scientific research and is intended for research purposes. Not medical advice.
Products related to this peptide are for in vitro laboratory research only. Not approved for human consumption.
Other peptides
